Mengyun Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mengyun Li has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Wencan Wu
State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, China
3 shared publications - Yikui Zhang
State Key Laboratory of Eye Health Eye Hospital Wenzhou Medical University Wenzhou China
3 shared publications - Hui Lin
Department of Cardiology, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, 315211, China
2 shared publications Shuaishuai Yu
School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325027, China
2 shared publicationsTian Xia
The Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, 325027, China
2 shared publications- Xian Shao
Department of Medical Research Center, Shaoxing People’s Hospital, Shaoxing, P. R. China
2 shared publications
Latest Publications
- 23 October 2025
- Published by Elsevier in Neuropharmacology
- Vol. 283, 110730
Olfactory ensheathing cells reduce trigeminal neuralgia pain and anxiety by suppressing P2X7R-mediated A1 Astrocyte activation in mice
- 23 October 2025
- Published by Elsevier in Neuropharmacology
- Vol. 283, 110730
Olfactory ensheathing cells reduce trigeminal neuralgia pain and anxiety by suppressing P2X7R-mediated A1 Astrocyte activation in mice
- 1 January 2025
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 53 (03) , 833-862
Neuroprotective Effects of Paeonia lactiflora Through the Regulation of Gut Dubosiella in an MPTP-Induced Parkinson’s Disease Mouse Model
Emerging evidence suggests that changes in the composition of the gut microbiota may play an important role in the pathogenesis of Parkinson’s disease (PD). Paeonia lactiflora Pall., a traditional Chinese medicinal herb belonging to the genus Paeonia, is commonly used in Chinese medicinal practice for the treatment of PD. However, the specific mechanisms of its action remain poorly understood. This study aimed to further determine the neuroprotective properties of Paeonia lactiflora Pall. water extract (PWE) in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model, and to investigate its potential implications for the pathogenesis of PD. A PD mouse model was established via the intraperitoneal administration of MPTP, followed by the assessment of motor function using behavioral tests. Western blotting and histopathological analysis were used to measure the levels of dopaminergic (DAergic) neurodegeneration-related factors in the midbrain (containing the substantia nigra (SN)) and striatum. 16S rRNA gene sequencing and metabolomic analysis were applied to identify differences in the gut microbiota and metabolites, respectively. Our results indicate that PWE effectively protects against MPTP-induced motor deficits, loss of DAergic neurons, blood-brain barrier (BBB) damage, and neuroinflammation in PD. The protective effects of PWE against PD are mediated through modulation of the gut microbiota, specifically by an increase in the abundance of the genus Dubosiella. In this study, we selected D. newyorkensis as a representative strain of the genus, and determined its therapeutic effects in an MPTP-induced PD mouse model. Our preliminary findings suggest that the neuroprotective effects of D. newyorkensis may be related to the production of serum indoleacetic acid.
- 1 January 2025
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 53 (03) , 833-862
Neuroprotective Effects of Paeonia lactiflora Through the Regulation of Gut Dubosiella in an MPTP-Induced Parkinson’s Disease Mouse Model
Emerging evidence suggests that changes in the composition of the gut microbiota may play an important role in the pathogenesis of Parkinson’s disease (PD). Paeonia lactiflora Pall., a traditional Chinese medicinal herb belonging to the genus Paeonia, is commonly used in Chinese medicinal practice for the treatment of PD. However, the specific mechanisms of its action remain poorly understood. This study aimed to further determine the neuroprotective properties of Paeonia lactiflora Pall. water extract (PWE) in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model, and to investigate its potential implications for the pathogenesis of PD. A PD mouse model was established via the intraperitoneal administration of MPTP, followed by the assessment of motor function using behavioral tests. Western blotting and histopathological analysis were used to measure the levels of dopaminergic (DAergic) neurodegeneration-related factors in the midbrain (containing the substantia nigra (SN)) and striatum. 16S rRNA gene sequencing and metabolomic analysis were applied to identify differences in the gut microbiota and metabolites, respectively. Our results indicate that PWE effectively protects against MPTP-induced motor deficits, loss of DAergic neurons, blood-brain barrier (BBB) damage, and neuroinflammation in PD. The protective effects of PWE against PD are mediated through modulation of the gut microbiota, specifically by an increase in the abundance of the genus Dubosiella. In this study, we selected D. newyorkensis as a representative strain of the genus, and determined its therapeutic effects in an MPTP-induced PD mouse model. Our preliminary findings suggest that the neuroprotective effects of D. newyorkensis may be related to the production of serum indoleacetic acid.
- 17 May 2023
- Published by Elsevier in Experimental Eye Research
- Vol. 233, 109514
Goats with low levels of AAV antibody may serve as candidates for large animal gene therapy
- 17 May 2023
- Published by Elsevier in Experimental Eye Research
- Vol. 233, 109514
Goats with low levels of AAV antibody may serve as candidates for large animal gene therapy
- 31 March 2022
- Published by Elsevier in Experimental Eye Research
- Vol. 219, 108956
High-quality, large-scale, semi-thin, & ultra-thin sections of the optic nerve in large animals: An optimized procedure
- 31 March 2022
- Published by Elsevier in Experimental Eye Research
- Vol. 219, 108956
High-quality, large-scale, semi-thin, & ultra-thin sections of the optic nerve in large animals: An optimized procedure
- Open Access
- 30 March 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Cold protection allows local cryotherapy in a clinical-relevant model of traumatic optic neuropathy
Therapeutic hypothermia (TH) is potentially an important therapy for central nervous system (CNS) trauma. However, its clinical application remains controversial, hampered by two major factors: (1) Many of the CNS injury sites, such as the optic nerve (ON), are deeply buried, preventing access for local TH. The alternative is to apply TH systemically, which significantly limits the applicable temperature range. (2) Even with possible access for ‘local refrigeration’, cold-induced cellular damage offsets the benefit of TH. Here we present a clinically translatable model of traumatic optic neuropathy (TON) by applying clinical trans-nasal endoscopic surgery to goats and non-human primates. This model faithfully recapitulates clinical features of TON such as the injury site (pre-chiasmatic ON), the spatiotemporal pattern of neural degeneration, and the accessibility of local treatments with large operating space. We also developed a computer program to simplify the endoscopic procedure and expand this model to other large animal species. Moreover, applying a cold-protective treatment, inspired by our previous hibernation research, enables us to deliver deep hypothermia (4 °C) locally to mitigate inflammation and metabolic stress (indicated by the transcriptomic changes after injury) without cold-induced cellular damage, and confers prominent neuroprotection both structurally and functionally. Intriguingly, neither treatment alone was effective, demonstrating that in situ deep hypothermia combined with cold protection constitutes a breakthrough for TH as a therapy for TON and other CNS traumas.
- 30 March 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Open AccessCold protection allows local cryotherapy in a clinical-relevant model of traumatic optic neuropathy
Therapeutic hypothermia (TH) is potentially an important therapy for central nervous system (CNS) trauma. However, its clinical application remains controversial, hampered by two major factors: (1) Many of the CNS injury sites, such as the optic nerve (ON), are deeply buried, preventing access for local TH. The alternative is to apply TH systemically, which significantly limits the applicable temperature range. (2) Even with possible access for ‘local refrigeration’, cold-induced cellular damage offsets the benefit of TH. Here we present a clinically translatable model of traumatic optic neuropathy (TON) by applying clinical trans-nasal endoscopic surgery to goats and non-human primates. This model faithfully recapitulates clinical features of TON such as the injury site (pre-chiasmatic ON), the spatiotemporal pattern of neural degeneration, and the accessibility of local treatments with large operating space. We also developed a computer program to simplify the endoscopic procedure and expand this model to other large animal species. Moreover, applying a cold-protective treatment, inspired by our previous hibernation research, enables us to deliver deep hypothermia (4 °C) locally to mitigate inflammation and metabolic stress (indicated by the transcriptomic changes after injury) without cold-induced cellular damage, and confers prominent neuroprotection both structurally and functionally. Intriguingly, neither treatment alone was effective, demonstrating that in situ deep hypothermia combined with cold protection constitutes a breakthrough for TH as a therapy for TON and other CNS traumas.